• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • AB Science – Masitinib
      • BrainStorm Cell Therapeutics – NurOwn
      • Clene Nanomedicine – CNM-Au8
      • ILB – Tikomed
      • Kadimastem – AstroRx
      • Mitsubishi Tanabe Pharma America – Oral Edaravone
      • Neuronata-R/Lenzumestrocel
      • NeuroSense – PrimeC
      • Neuvivo – NP001
      • Prilenia Therapeutics – Pridopidine
      • SOD1 Therapies & Trials
      • SPG302
      • T Regulatory Cell Therapies
      • Ulefnersen – Ionis Pharmaceuticals
    • Approved Drugs
      • Nuedexta
      • Radicava/Edaravone
      • Riluzole/Tiglutik
      • Rozebalamin/Methylcobalamin
      • Tofersen/Qalsody
    • Drugs No Longer in Development
      • Amylyx – AMX0035
      • Collaborative Medicinal Development – CuATSM
      • Cytokinetics – Reldesemtiv
      • Orphazyme – Arimoclomol
      • TUDCA Trial
  • Support for Health Professionals
    • Breaking the News in ALS/MND
  • Events/Programs
    • Calendar of Events/Programs
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • International Symposium
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

Forum Guidelines

International Alliance of ALS/MND Associations › Forums › Member Forum › Forum Guidelines

  • This topic has 0 replies, 1 voice, and was last updated 9 years, 11 months ago by Admin.
Viewing 1 post (of 1 total)
  • Author
    Posts
  • August 15, 2016 at 9:48 am #2059
    Admin
    Keymaster

      While writing on the forum, we expect all members to treat one another with respect, even if we may disagree. Our Executive Director will moderate the forum to the best of her ability. Please alert Cathy (alliance@als-mnd.org) if anyone is misusing the forum. We hope this is a wonderful resource for all of our members.

      • This topic was modified 6 years, 4 months ago by International Alliance.
      • This topic was modified 6 years, 4 months ago by Admin.
    • Author
      Posts
    Viewing 1 post (of 1 total)
    • You must be logged in to reply to this topic.
    Log In

    Primary Sidebar

    • João Marcos Andrietta, Brazil

      João Marcos Andrietta, Brazil

    • Eddy Lefrancois, Canada

      Eddy Lefrancois, Canada

    • Glen Victor Peters, Australia

      Glen Victor Peters, Australia

    • David Bishop, UK

      David Bishop, UK

    • Magdalena Ayala Rodríguez, Mexico

      Magdalena Ayala Rodríguez, Mexico

    • Chun Ju Xiao, China

      Chun Ju Xiao, China

    • Shay Rishoni, Israel

      Shay Rishoni, Israel

    • Margreth Burger-Saile, Switzerland

      Margreth Burger-Saile, Switzerland

    • Diana Fernandez, Argentina

      Diana Fernandez, Argentina

    • Yannick Richard, Canada

      Yannick Richard, Canada
      yannickrichard

    • Cath Muir, UK

      Cath Muir, UK
      Cath

    • Catherine Pearce, Australia

      Catherine Pearce, Australia

    • Ann Nicol, USA

      Ann Nicol, USA

    • David Solomon, UK

      David Solomon, UK

    • Brigitte Wernli, Switzerland

      Brigitte Wernli, Switzerland

    • Soledad Rodriguez, Spain

      Soledad Rodriguez, Spain

    • PALS and CALS, Singapore

      PALS and CALS, Singapore

    • Natalya Rybakova, Russia

      Natalya Rybakova, Russia

    • Phil Rossall, UK

      Phil Rossall, UK

    • Zabun Nassar, England

      Zabun Nassar, England

    • Greg Heydet, USA

      Greg Heydet, USA

    • Stephanie Christiansen Hall, Canada

      Stephanie Christiansen Hall, Canada

    • Jo Knowlton, Scotland

      Jo Knowlton, Scotland

    • Sanjay Kumar Srivastava, India

      Sanjay Kumar Srivastava, India

    • Anderson Custodio Pinto, Brazil

      Anderson Custodio Pinto, Brazil

    • Eddy LeFrançois, Canada

      Eddy LeFrançois, Canada

    • Roy Taylor, Ireland

      Roy Taylor, Ireland
      roy

    • Brian Lovell, Australia

      Brian Lovell, Australia

    • H. Todd Kelly, USA

      H. Todd Kelly, USA

    • Jeff Sutherland, Canada

      Jeff Sutherland, Canada
      jspic

    • Peng Yi-Wen, Taiwan

      Peng Yi-Wen, Taiwan

    • Yessenia Hernandez Mendoza, Mexico

      Yessenia Hernandez Mendoza, Mexico

    • Angelique van der Lit-van Veldhuizen, Netherlands

      Angelique van der Lit-van Veldhuizen, Netherlands

    • Paul Launer, USA

      Paul Launer, USA

    • Fabio Carvalho, Brazil

      Fabio Carvalho, Brazil

    • Irene McCaughey, Australia

      Irene McCaughey, Australia

    • Norm MacIsaac, Canada

      Norm MacIsaac, Canada

    • Rosie Riley, USA

      Rosie Riley, USA

    • Barry de Reuver, Netherlands

      Barry de Reuver, Netherlands

    • Marcelo Farinelli, Brazil

      Marcelo Farinelli, Brazil

    • Graham Johnson, Australia

      Graham Johnson, Australia

    • Frank Bos, Netherlands

      Frank Bos, Netherlands

    • Ching-Liang Chu, Taiwan

      Ching-Liang Chu, Taiwan

    • Tso-Ta Huang, Taiwan

      Tso-Ta Huang, Taiwan

    • Lucy Lintott, Scotland

      Lucy Lintott, Scotland

    • Chen Chun-Chin, Malaysia

      Chen Chun-Chin, Malaysia

    • Laurie Petit-Jean, France

      Laurie Petit-Jean, France

    • Leon Ryba, Argentina

      Leon Ryba, Argentina

    • Dick Dayton, USA

      Dick Dayton, USA

    • Francisco Perez Palop, Spain

      Francisco Perez Palop, Spain

    Learn more about the March of Faces

    Footer

    Stay connected to the global ALS/MND community.

    Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

     
    This field is for validation purposes and should be left unchanged.
    • Email
    • Facebook
    • LinkedIn
    • Twitter
    • YouTube
    Return to top of page

    Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

    Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


    Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login